Investors focused on the Medical space have likely heard of The Ensign Group (ENSG), but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

The Ensign Group is one of 833 individual stocks in the Medical sector. Collectively, these companies sit at #2 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. ENSG is currently sporting a Zacks Rank of #1 (Strong Buy).

The Zacks Consensus Estimate for ENSG's full-year earnings has moved 6.92% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

Based on the most recent data, ENSG has returned 30.88% so far this year. Meanwhile, stocks in the Medical group have gained about 10.46% on average. This shows that The Ensign Group is outperforming its peers so far this year.

Breaking things down more, ENSG is a member of the Medical - Nursing Homes industry, which includes 6 individual companies and currently sits at #101 in the Zacks Industry Rank. Stocks in this group have gained about 16.76% so far this year, so ENSG is performing better this group in terms of year-to-date returns.

Investors in the Medical sector will want to keep a close eye on ENSG as it attempts to continue its solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
The Ensign Group, Inc. (ENSG) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.